You have searched for "Cushing"
Showing 261-270 of 287
LONDON: Oil prices settled higher on Wednesday, supported by a draw in U.S. crude inventories and Britain's approval of a second coronavirus vaccine but pressured by swelling year-over-year supply.
NEW YORK: Oil prices rose to their highest levels since February on Wednesday after Saudi Arabia announced a big voluntary production cut and on a steep fall in U.S. crude inventories
NEW YORK: Oil prices steadied on Thursday after industry data showed a surprise increase in U.S. crude inventories that revived pandemic-related fuel demand concerns, while U.S. stimulus hopes buoyed prices.
NEW YORK: Oil prices were little changed on Wednesday, despite a massive drawdown in U.S. crude inventories, as ongoing concerns about the coronavirus pandemic tempered buying interest.
NEW YORK: Oil prices settled more than 2% higher on Monday, buoyed by falling U.S. crude inventories and rising winter fuel demand due to one of the worst snowstorms to hit the U.S. Northeast in years.
Kuala Lumpur: Analysts said the unknown pace of vaccination programmes mean the world's largest medical gloves maker could command a higher price for its stock by listing sooner rather than later, while the firm when announcing its plan on Friday talked up post-pandemic sales likely exceeding pre-pandemic levels.
TAIPEI (Reuters) - Singapore's sovereign wealth fund GIC sold Taiwan stocks last week, cashing in on the island's booming bourse, three sources with direct knowledge of the situation told Reuters.
Singapore-listed Jardine Matheson, whose businesses include construction, aviation and automotive, has offered to pay $33 in cash for each Jardine Strategic share, representing a premium of 20% to the stock's closing price on Friday.
NEW YORK: Oil prices rose on Wednesday on an upbeat forecast for global economic recovery and as U.S. gasoline inventories plummeted, but prices were limited due to a surge in crude oil inventories in the aftermath of last month's Texas winter storm.
HONG KONG (Reuters) - Some of Ant Group's global investors have valued the Chinese fintech firm at over US$200bil based on its 2020 performance, said people with knowledge of the matter, offering a more sober estimate after the shelving of its IPO and forced restructuring.